Big bucks for infrastructure in latest ARC round
Friday, 04 October, 2002
Life science related infrastructure projects have been funded to the tune of nearly $10.5 million in the latest round of Australian Research Council linkage, infrastructure and equipment (LIEF) grants.
The grants range in size from $100,000 for a quantitative PCR facility based at the University of New England, to a massive $1.584 million fillip awarded to a consortium of five NSW and ACT universities for a NMR spectrometer for molecular structure function analysis.
The LIEF grant scheme is designed to encourage research institutions to collaborate, develop research infrastructures and form large-scale cooperative initiatives.
Notable recipients in the latest round include:
- A grant of $500,000 to a group headed by Prof Perry Bartlett of the university of Queensland, Griffith University and Queensland University of Technology to develop a cell sorter facility for neuroscience and related biotechnology.
- $630,000 for a joint facility for plant genetic analysis and gene discovery in WA, headed by Prof Mike Jones and colleagues at Murdoch University and the University of WA.
- A grant of $500,000 for the developmenmt of a South Australian supercomputing facility, whose partners include the University of Adelaide, Flinders University, the University of South Australia and Northern Territory University.
- $630,000 for a functional genomics analysis facility to improve DNA analysis and data management between five universities in the Sydney and Newcastle area.
- $218,000 for the establishment of the Adelaide Mass Spectrometry Facility, involving the University of Adelaide, Flinders University, the Institute for Medical and veterinary Science and TGR Biosciences.
- A grant of $400,000 for a high-performance computing and web facility for genome bioinformatics between the University of Queensland and QUT.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
